▼ This medicinal product is subject to additional monitoring. Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellow Card in Google Play or Apple App Store. Adverse events should also be reported to Ipsen via email at pharmacovigilance.uk-ie@ipsen.com or phone on 01753 627777.
PBC HCP Guide
Primary Biliary Cholangitis (PBC)
File
6 pages
This booklet, intended for HCPs only, provides an overview of IQIRVO including which PBC patients are eligible, how it works, dosing, special considerations as well as efficacy and safety data.
IQV-UK-000154 | November 2024
